MATTERN PHARMA AG
6Patents
6Active
6Granted
44Portfolio score
Filing activity: Jul 29, 2011 → Dec 10, 2015
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8784882B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 67 | Active |
| US8877230B2 | Controlled release delivery system for nasal applications | Human Necessities | 14 | Active |
| US8784869B2 | Controlled release delivery system for nasal applications and methods of treatment | Human Necessities | 13 | Active |
| US9186320B2 | Controlled release delivery system for nasal application of neurotransmitters | Human Necessities | 8 | Active |
| US9238072B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 7 | Active |
| US9579280B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 6 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.